SynthesisMedicine2022

Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating non-Hodgkin lymphoma: A systematic review and meta-analysis of clinical trials.

Jiaheng Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.